Epithelial Cell Transforming Sequence 2 Oncogene (ECT2) Peptide
ECT2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN939857
Quick Overview for Epithelial Cell Transforming Sequence 2 Oncogene (ECT2) Peptide (ABIN939857)
Target
ECT2
(Epithelial Cell Transforming Sequence 2 Oncogene (ECT2))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- KKHTADENPD KSTLEKAIGS LKEVMTHINE DKRKTEAQKQ IFDVVYEVDG
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ECT2 antibody,
Alternative Names: ECT2 control peptide, ECT2 antibody Blocking Peptide, Anti-ECT2 Blocking Peptide, Epithelial Cell Transforming Sequence 2 Oncogene Blocking Peptide, FLJ10461 Blocking Peptide, MGC138291 Blocking Peptide, ECT2, ECT-2, ECT 2, ECT-2 Blocking Peptide, ECT 2 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- ECT2 (Epithelial Cell Transforming Sequence 2 Oncogene (ECT2))
-
Background
- ECT2 is a transforming protein that is related to Rho-specific exchange factors and yeast cell cycle regulators. The expression of ECT2 is elevated with the onset of DNA synthesis and remains elevated during G2 and M phases. In situ hybridization analysis showed that expression is at a high level in cells undergoing mitosis in regenerating liver. Thus, this protein is expressed in a cell cycle-dependent manner during liver regeneration, and is thought to have an important role in the regulation of cytokinesis.
-
Molecular Weight
- 100 kDa
Target
-
You are here:
